Source: Eur Respir Monogr 2017; 75: 245-252
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Nicolas Schönfeld. Perspectives on antibiotic treatment of NTM pulmonary disease. Eur Respir Monogr 2017; 75: 245-252

Member's Comments

No comment yet.

Related content which might interest you: New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 Microbiological diagnosis of NTM pulmonary disease Source: International Congress 2017 – Clinical impact of nontuberculous mycobacterial (NTM) disease Year: 2017 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Bacteria, antibiotics and COPD Source: Eur Respir J 2001; 17: 995-1007 Year: 2001 Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease Source: Eur Respir J 2016; 48: 928-931 Year: 2016 Diagnosis and treatment‘s management of the MDR tuberculosis in a chronic pulmonary diseases department Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 Aspects of diagnosis and treatment in pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 168s Year: 2002 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Limitations of immune-based diagnostics in patients suspected for pulmonary tuberculosis Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009 Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016 Year: 2017 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Non-tuberculous mycobacterial pulmonary disease Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019 Year: 2019 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020